Your SlideShare is downloading. ×
0
The Uppsala Biotech Master Case Overview Dr. Robin Teigland, Master Case Facilitator Master of Business Administration Pro...
Purpose <ul><li>The purpose of this document is to provide potential MBA students with a flavor of MBA Live by presenting ...
Overview of Uppsala Biotech Master Case  <ul><li>Introduction to SSE MBA Students </li></ul><ul><li>Introduction to Uppsal...
Countries represented Sweden (25%)  United States  Latvia Germany Estonia France Japan Iceland Venezuela/Spain Netherlands...
Some SSE MBA Students Björn Svensson 43, Sweden Management Consultant Cap Gemini Peter Vriesman 32, Holland Engineer, Elec...
Overview of Uppsala Biotech Master Case  <ul><li>Introduction to SSE MBA Students </li></ul><ul><li>Introduction to Uppsal...
The Three SSE MBA Master Cases in 2004-2005 <ul><li>Pulp and paper products </li></ul><ul><li>Capital-intensive </li></ul>...
The Uppsala Biotech Master Case <ul><li>A collaborative effort   that runs  April to June 2005  between Uppsala BIO and SS...
The Uppsala Biotech Master Case:  Integrating the Micro and Macro Levels Issues Shaping Nordic Competitiveness in Bioscien...
What is Biotechnology? A group of techniques and technologies that apply the principles of genetics, immunology, and molec...
What is a Biotechnology Cluster? Biotech firms Other firms, e.g., suppliers, customers Academic and private  research orga...
Uppsala – A Biotech Hotbed One of the world’s most biotech-concentrated cities? <ul><li>Tools for life science </li></ul><...
Unbroken Tradition of  Scientific Achievement in Uppsala Century Scientist Achievement Nobel prize 18th  O. Rudbeck The ly...
Uppsala Biotech Master Case: Focused  yet   Combined with Seeing the Big Picture <ul><li>Phase I. Sponsor Organization Key...
Sponsor Organizations in the  Uppsala Biotech Master Case  Larger firms:  Pharmacia Diagnostics, GE Healthcare Funding age...
Cooperation with the  Uppsala Bio Cluster Initiative Madeleine Neil  Uppsala BIO Communications 018-57 23 53  0768-29 77 7...
Uppsala Biotech MC Sponsor Organizations Year founded in Uppsala No. empl. Company description BIO-X 2004 0 Cross-discipli...
Uppsala Biotech MC - Schedule Phase I Sponsor Organization Key Issue April 12-15 <ul><li>Dynamics of Regional Innovation S...
Uppsala Biotech MC  Activities and Supporting Deliverables Phase I Activity: Sponsor Organization Key Issue Deliverable Ki...
Uppsala Biotech MC Deliverables at a Glance Phase I Deliverable: Sponsor Organization Key Issue Due Presented % grade Regi...
Overview of Uppsala Biotech Master Case  <ul><li>Introduction to SSE MBA Students </li></ul><ul><li>Introduction to Uppsal...
Uppsala Biotech MC - Schedule Phase I Sponsor Organization Key Issue April 12-15 <ul><li>Dynamics of Regional Innovation S...
The Dynamics of Regional Innovation Systems I Course Visiting Professor Mary Walshok, Univ. Of California, San Diego April...
The Uppsala Biotech Master Case Kick-off Master of Business Administration Program (MBA) Stockholm School of Economics (SS...
Master Case Kick-off Day in Uppsala  Friday,  April  22 <ul><li>Bus leaves Sveavägen 65  (Leaves at 8:30 sharp) </li></ul>...
<ul><li>Uppsala BIO – Science Park  (9:30 -12:00) Dag Hammarskjölds väg 60, Uppsala (The bus will leave Sveavägen 65 at 8:...
Map of Uppsala Bio and Research Labs Uppsala BIO
(2) Visit to Research Labs  (12:30 – 15:00) <ul><li>BMC Lab, www.bmc.uu.se </li></ul><ul><ul><li>Resistentia and Svanova t...
(2) Uppsala Biotech MC Teams Rudbeck Lab Student names in red are team contacts Ångström Lab BMC Lab BIO-X QUIAtech Resist...
(3a) Visit to Sponsor Organizations  (15:30 – 17:30) <ul><li>BIO-X </li></ul><ul><ul><li>Company contact: Rhiannon Sanders...
(3b) Visit to Sponsor Organizations  (15:30 – 17:30) <ul><li>QUIAtech </li></ul><ul><ul><li>Company contact: Karen Frost, ...
(3c) Sponsor Organization Kick-off Visit: Suggested Activities  <ul><li>Presentations </li></ul><ul><ul><li>MBA Team prese...
(4) Mingle Dinner at Värmlands Nation,   (18-20:30, Bus leaves at 20:45) <ul><li>Värmlands nation </li></ul><ul><ul><li>Co...
(4) Mingle with CEF Students <ul><li>We will be joined at the dinner by students from the Masters program at the Centre fo...
The Uppsala Biotech Master Case Phase I Deliverables Master of Business Administration Program (MBA) Stockholm School of E...
Uppsala Biotech MC  Sponsor Organizations & Key Issues* BIO-X *Projects have been generalized due to confidentiality aspec...
The Next Few Weeks in Phase I <ul><li>Friday, June 3rd </li></ul><ul><ul><li>Biotech Day I </li></ul></ul><ul><ul><li>5 mi...
Uppsala Biotech MC Phase I Deliverables <ul><li>Final Presentation </li></ul><ul><ul><li>PPT presentation </li></ul></ul><...
Criteria for Uppsala Biotech MC Phase I Deliverables <ul><li>Key issue analysis </li></ul><ul><ul><li>Clear purpose of inv...
Uppsala Biotech MC Deliverables – Final Presentation Biotech Day I, June 3rd <ul><li>Biotech Day 5 Minute Presentation (A)...
Uppsala Biotech MC Deliverables – Final Report Due June 12th, 13:00 <ul><li>Remember who the reader is! </li></ul><ul><ul>...
The Uppsala Biotech Master Case Biotech Day Master of Business Administration Program (MBA) Stockholm School of Economics ...
Uppsala Biotech Day I – June 3rd, 2005 At SSE MBA <ul><li>Morning Coffee Mingle   </li></ul><ul><li>Overview of Uppsala Bi...
Feedback by Sponsor Organization to MBA Team <ul><li>Please prepare a brief presentation on the following: </li></ul><ul><...
Overview of Uppsala Biotech Master Case  <ul><li>Introduction to SSE MBA Students </li></ul><ul><li>Introduction to Uppsal...
Uppsala Biotech MC - Schedule Phase I Sponsor Organization Key Issue April 12-15 <ul><li>Dynamics of Regional Innovation S...
Dynamics of Regional Innovation Systems II Course Trip to San Diego, June 18-25, with Prof. M. Walshok  Itinerary CO    69...
The Final Stretch  Uppsala Biotech MC Phase II Deliverables Master of Business Administration Program (MBA) Stockholm Scho...
The Final Stretch <ul><li>Friday, June 24 th  (in San Diego) </li></ul><ul><ul><li>Presentation of Symposium Poster Presen...
Uppsala Biotech MC Phase II Deliverables <ul><li>Symposium Poster Presentation </li></ul><ul><ul><li>Presentation to fit w...
Poster Presentation <ul><li>What is a poster? </li></ul><ul><ul><li>A visually accessible summary of a project </li></ul><...
Biotech Symposium MBA Student Poster Themes <ul><li>MBA Team Uppsala BIO-X </li></ul><ul><ul><li>How to attract “smart mon...
Criteria for Uppsala Biotech MC Phase II Deliverables <ul><li>Key theme analysis </li></ul><ul><ul><li>Clear focus </li></...
Uppsala Biotech MC Phase II Deliverables <ul><li>Remember who the reader is! </li></ul><ul><ul><li>These deliverables are ...
Symposium on  Issues Shaping Nordic  Competitiveness in Biotechnology Stockholm School of Economics (SSE) Master of Busine...
Symposium Practical Activities by Students <ul><li>Symposium Set-up (7:30 to 9:00) </li></ul><ul><ul><li>MBA Team BIO-X </...
SSE MBA Student Participation in Symposium <ul><li>Presentation of SSE MBA in Symposium Introduction </li></ul><ul><ul><li...
  Issues Shaping Nordic Competitiveness in Biotechnology SSE MBA Inaugural Symposium June 30th, Stockholm School of Econom...
SSE MBA Biotech Symposium Time   Event   Thursday, June 30, 2005 Registration Symposium Welcome  Robin Teigland, SSE MBA S...
Issues Shaping Nordic Competitiveness in Biotechnology June 30, 2005 9:00 to 14:00 Stockholm School of Economics Sveavägen...
SESSION I. THE COMPANY PERSPECTIVE Keynote Speaker:  Mads Øvlisen Chairman of the Board, Novo Nordisk A/S Mads Øvlisen is ...
SSE MBA Poster Themes Improving Commercialization of Research How to Choose VC Funding  Interested in China for Biotech R&...
Symposium Write-up in Sweden’s Largest Newspaper
More Symposium Information <ul><li>For more information on the symposium, please visit SwedenBio’s homepage at www.swedenb...
Uppsala Biotech MC Contact Information <ul><li>Robin Teigland </li></ul><ul><li>Uppsala Biotech MC Coach </li></ul><ul><li...
Upcoming SlideShare
Loading in...5
×

Uppsala Biotech Master Case Overview

3,594

Published on

This gives an overview of a Live Case on the Uppsala Biotech Cluster that I ran in the MBA program at the Stockholm School of Economics in 2005.

Published in: Business, Education
1 Comment
0 Likes
Statistics
Notes
  • Fioricet is often prescribed for tension headaches caused by contractions of the muscles in the neck and shoulder area. Buy now from http://www.fioricetsupply.com and make a deal for you.
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
  • Be the first to like this

No Downloads
Views
Total Views
3,594
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
86
Comments
1
Likes
0
Embeds 0
No embeds

No notes for slide
  • Transcript of "Uppsala Biotech Master Case Overview"

    1. 1. The Uppsala Biotech Master Case Overview Dr. Robin Teigland, Master Case Facilitator Master of Business Administration Program (MBA) Stockholm School of Economics (SSE) April to June 2005 www.sse.edu/ssemba
    2. 2. Purpose <ul><li>The purpose of this document is to provide potential MBA students with a flavor of MBA Live by presenting an overview of the Uppsala Biotech Master Case that took place April to June 2005. </li></ul><ul><li>This document describes some of the activities and events during this Master Case and is based on actual materials used. </li></ul><ul><li>If there are any questions about this Master Case or about MBALive in general, please do not hesitate to contact Master Case Coach Robin Teigland at robin.teigland@hhs.se. More information on Robin Teigland can also be found at www.knowledgenetworking.org. </li></ul>
    3. 3. Overview of Uppsala Biotech Master Case <ul><li>Introduction to SSE MBA Students </li></ul><ul><li>Introduction to Uppsala Biotech Master Case </li></ul><ul><li>Overview of Uppsala Biotech MC Phase I </li></ul><ul><ul><li>Dynamics of Regional Innovation Systems with Prof. Walshok </li></ul></ul><ul><ul><li>Uppsala Biotech Master Case Kick-off in Uppsala </li></ul></ul><ul><ul><li>Phase I Deliverables </li></ul></ul><ul><ul><li>Biotech Day I </li></ul></ul><ul><li>Overview of Uppsala Biotech MC Phase II </li></ul><ul><ul><li>Dynamics of Regional Innovation Systems with Prof. Walshok, trip to San Diego </li></ul></ul><ul><ul><li>Phase II Deliverables </li></ul></ul><ul><ul><li>Biotech Symposium </li></ul></ul>
    4. 4. Countries represented Sweden (25%) United States Latvia Germany Estonia France Japan Iceland Venezuela/Spain Netherlands Denmark India Argentina Turkey Switzerland United Kingdom Greece Total of 36 students Average age: 31 Average no. working years: 6.5 SSE MBA Students – Class of 2005 Educational background
    5. 5. Some SSE MBA Students Björn Svensson 43, Sweden Management Consultant Cap Gemini Peter Vriesman 32, Holland Engineer, Electrolux Santosh Nair, India 28, BSc Business Project Manager Patrik Bosander 32, London, MSc KTH Managing Director UK software provider Arwen Schreiber, USA 28, BA, Operations Silicon Valley startups Karin Fisher, 30 Hong Kong, BA, Founder Asian media startup Jeanette Del Valle, 36 Venezuela, BA General Manager Entertainment firm Taavi Lepmets 30, Latvia, Founder LHV, largest investment bank in Baltics Roger Jacobsson, 37 Sweden, Ericsson Business Manager Richard Brorsson, SE 34, MSc Business, Business Development Manager European Commission
    6. 6. Overview of Uppsala Biotech Master Case <ul><li>Introduction to SSE MBA Students </li></ul><ul><li>Introduction to Uppsala Biotech Master Case </li></ul><ul><li>Overview of Uppsala Biotech MC Phase I </li></ul><ul><ul><li>Dynamics of Regional Innovation Systems with Prof. Walshok </li></ul></ul><ul><ul><li>Uppsala Biotech Master Case Kick-off in Uppsala </li></ul></ul><ul><ul><li>Phase I Deliverables </li></ul></ul><ul><ul><li>Biotech Day I </li></ul></ul><ul><li>Overview of Uppsala Biotech MC Phase II </li></ul><ul><ul><li>Dynamics of Regional Innovation Systems with Prof. Walshok, trip to San Diego </li></ul></ul><ul><ul><li>Phase II Deliverables </li></ul></ul><ul><ul><li>Biotech Symposium </li></ul></ul>
    7. 7. The Three SSE MBA Master Cases in 2004-2005 <ul><li>Pulp and paper products </li></ul><ul><li>Capital-intensive </li></ul><ul><li>Seven centuries old </li></ul><ul><li>Large multinational </li></ul><ul><li>Publicly listed </li></ul><ul><li>B2B </li></ul><ul><li>Financial services </li></ul><ul><li>Information-intensive </li></ul><ul><li>Mid-sized national company </li></ul><ul><li>Strong local roots </li></ul><ul><li>Customer-owned (federation) </li></ul><ul><li>B2C </li></ul><ul><li>Biotech </li></ul><ul><li>Knowledge-intensive </li></ul><ul><li>Networked organizations </li></ul><ul><li>From start-ups to large firms </li></ul><ul><li>Ethically complex </li></ul><ul><li>B2B, B2C, “Research 2 Business” </li></ul>MC1 (Fall): StoraEnso MC2 (Winter): LF (Länsförsäkringar) MC3 (Spring): The Uppsala Biotech Cluster
    8. 8. The Uppsala Biotech Master Case <ul><li>A collaborative effort that runs April to June 2005 between Uppsala BIO and SSE in which students put their MBA skills into action </li></ul><ul><li>An opportunity for a number of Uppsala biotech organizations to get qualified external insights on a current Key Issue in their organization </li></ul><ul><ul><li>Six Uppsala Biotech Sponsor Organizations each appointed a dedicated MBA Team of students (6 students per MBA Team) to work on a Key Issue </li></ul></ul><ul><ul><ul><li>Students conduct independent, theory-informed analyses of the Key Issue and… </li></ul></ul></ul><ul><ul><ul><li>… .produce and present a report with recommendations on the Key Issue for their UB Sponsor Organization </li></ul></ul></ul><ul><ul><li>Opportunity to interact and learn together with an international, experienced group of MBA students </li></ul></ul><ul><ul><ul><li>Each student spends approximately 100 working hours on the UB Master Case, totaling around 600 person-hours to work with each UB Sponsor Organization and analyze its Key Issue ! </li></ul></ul></ul><ul><li>An opportunity for Uppsala BIO and its firms to gain informed insights into innovation and entrepreneurial processes and cluster dynamics from across the globe </li></ul>
    9. 9. The Uppsala Biotech Master Case: Integrating the Micro and Macro Levels Issues Shaping Nordic Competitiveness in Bioscience: The Uppsala Case Each MBA Team investigates the issues shaping the competitiveness of the Uppsala Biotech Cluster and forms an opinion on how competitiveness could be improved <ul><li>MC Sponsor Organization Key Issue </li></ul><ul><ul><li>Each MBA Team investigates and develops recommendations for a Key Issue for one Uppsala Biotech Sponsor Organization </li></ul></ul>
    10. 10. What is Biotechnology? A group of techniques and technologies that apply the principles of genetics, immunology, and molecular, cellular and structural biology to the discovery and development of novel products – Audretsch 2001
    11. 11. What is a Biotechnology Cluster? Biotech firms Other firms, e.g., suppliers, customers Academic and private research organizations Interaction Financing and venture capital firms Government, e.g., policy makers, funding agencies, etc. Support organizations, e.g., patent, consulting & law firms, etc. Enhanced innovation through local interaction
    12. 12. Uppsala – A Biotech Hotbed One of the world’s most biotech-concentrated cities? <ul><li>Tools for life science </li></ul><ul><li>Pharmaceuticals and biomedical devices </li></ul><ul><li>Diagnostics </li></ul>Expertise Areas More information at www.uppsalabio.com
    13. 13. Unbroken Tradition of Scientific Achievement in Uppsala Century Scientist Achievement Nobel prize 18th O. Rudbeck The lymphatic system 18th C. Linnæus Systema Naturæ classification 18th A. Celcius Thermometric scale (°C) 18th J.J. Berzelius Chemical elements (Se, Th, Si, Ti, Z) 19th A. J. Ångström Modern spectroscopy (Å unit) 19-20th M. Siegbahn X-ray spectroscopy 19-20th T. Svedberg Ultracentrifuge 20th A. Tiselius Electrophoresis 20th K. Siegbahn Electron spectroscopy 20th J.Porath, P. Flodin Gel filtration 20th G. Johansson, Immunoglobulin E H. Bennich, L. Wide C. Linnæus T. Svedberg A. Tiselius
    14. 14. Uppsala Biotech Master Case: Focused yet Combined with Seeing the Big Picture <ul><li>Phase I. Sponsor Organization Key Issue </li></ul><ul><ul><li>Each MBA Team works with one Uppsala Biotech Sponsor Organization to investigate and develop recommendations for a Key Issue for that organization </li></ul></ul><ul><ul><li>Key Issues may be related to financing, strategy, marketing, organization, operations, etc. (See appendix for suggestions.) </li></ul></ul><ul><li>Phase II. Cluster Dynamics and Nordic Competitiveness in Biotechnology </li></ul><ul><ul><li>Each MBA Team works on developing an understanding of the competitiveness of the Uppsala Biotech Cluster as well as participates in the SSE MBA Symposium on Issues Shaping Nordic Competitiveness in Biotechnology </li></ul></ul>
    15. 15. Sponsor Organizations in the Uppsala Biotech Master Case Larger firms: Pharmacia Diagnostics, GE Healthcare Funding agencies, e.g., Vinnova Research organizations, e.g., BMC, Rudbeck, Ångström Interaction Venture capital: HealthCap Smaller organizations: BIO-X , QUIAtech, Resistentia, Svanova Support organizations, e.g., Uppsala Innovation Center, Uppsala BIO, Intersecta Cluster dynamics Sponsor organizations in red
    16. 16. Cooperation with the Uppsala Bio Cluster Initiative Madeleine Neil Uppsala BIO Communications 018-57 23 53 0768-29 77 77 [email_address] www.uppsalabio.com <ul><li>An initiative between the local biotech industry, two Uppsala universities, and regional development bodies </li></ul><ul><li>Goal: To establish the Uppsala – Stockholm region as one of the world’s five leading biotech regions within five years </li></ul>                                                              
    17. 17. Uppsala Biotech MC Sponsor Organizations Year founded in Uppsala No. empl. Company description BIO-X 2004 0 Cross-disciplinary research project with researchers from academia and industry to develop tools for analysis of biomolecules 2000 ~15 Developing tools for genetic analysis, molecular diagnostics, and gene-based therapeutics 1998 ~20 Developing vaccines for treatment of allergies and asthma 2001 ~25 Offering products for diagnosing infectious diseases in livestock 1950s ~600 World leader in blood allergy testing 1940s ~1500 Developing systems & tools for discovery and development of drugs and for manufacture of biopharmaceuticals
    18. 18. Uppsala Biotech MC - Schedule Phase I Sponsor Organization Key Issue April 12-15 <ul><li>Dynamics of Regional Innovation Systems I (With Prof. Walshok) </li></ul><ul><ul><li>Tools for mapping the Uppsala Biotech Cluster </li></ul></ul>April 22 <ul><li>Kick-off Day in Uppsala </li></ul><ul><ul><li>Meet Uppsala BIO, researchers, Sponsor Organizations, and CEF participants </li></ul></ul>April 25 – June 3 <ul><li>Sponsor Organization Key Issue </li></ul><ul><ul><li>Key Issue development </li></ul></ul><ul><ul><li>Key Issue analysis and recommendations preparation </li></ul></ul>June 3 <ul><li>Uppsala Bio Day I at SSE </li></ul><ul><ul><li>Key Issue Report Presentation to Sponsor Organizations </li></ul></ul>Phase II Nordic Competitiveness in Biotechnology June 6 - 30 <ul><li>Dynamics of Regional Innovations Systems II (With Prof. Walshok) </li></ul><ul><ul><li>Comparing cluster dynamics – Uppsala and San Diego </li></ul></ul><ul><ul><li>Trip to San Diego </li></ul></ul><ul><li>Nordic Competitiveness in Biotechnology </li></ul><ul><ul><li>Investigation and assignment preparation </li></ul></ul>June 30 <ul><li>SSE MBA Symposium </li></ul><ul><ul><li>Symposium on Issues Shaping Nordic Competitiveness in Biotechnology </li></ul></ul>
    19. 19. Uppsala Biotech MC Activities and Supporting Deliverables Phase I Activity: Sponsor Organization Key Issue Deliverable Kick-off Regional Innovation System Presentation Team field visit Field Visit Poster Developing the key issue Key Issue Description Developing key issue recommendations Group Presentation: Key Issue Description & Solution Sketch Uppsala Biotech Day I Presentation of Key Issue Recommendations Delivering value Key Issue Recommendations Final Report Phase II Activity: Nordic Competitiveness in Biotechnology Deliverable Forming an opinion Poster Presentation & Hand-out Presenting an opinion Participation in SSE MBA Symposium
    20. 20. Uppsala Biotech MC Deliverables at a Glance Phase I Deliverable: Sponsor Organization Key Issue Due Presented % grade Regional Innovation System Presentation April 20 April 22 -- Field Visit Poster April 25, 13:15 April 25 -- Key Issue Description May 4, 23:59 May 6 10 Group Presentation: Key Issue Description & Solution Sketch May 11, 23:59 May 13 10 Presentation of Recommendation to Sponsor Organization May 27, 23:59 June 3 50 Key Issue Recommendation Final Report June 12, 13:00 N/A Phase II Deliverable: Nordic Competitiveness in Biotechnology Poster Presentation & Hand-out June 28, midnight June 30 30 Participation in Symposium June 30 --
    21. 21. Overview of Uppsala Biotech Master Case <ul><li>Introduction to SSE MBA Students </li></ul><ul><li>Introduction to Uppsala Biotech Master Case </li></ul><ul><li>Overview of Uppsala Biotech MC Phase I </li></ul><ul><ul><li>Dynamics of Regional Innovation Systems with Prof. Walshok </li></ul></ul><ul><ul><li>Uppsala Biotech Master Case Kick-off in Uppsala </li></ul></ul><ul><ul><li>Phase I Deliverables </li></ul></ul><ul><ul><li>Biotech Day I </li></ul></ul><ul><li>Overview of Uppsala Biotech MC Phase II </li></ul><ul><ul><li>Dynamics of Regional Innovation Systems with Prof. Walshok, trip to San Diego </li></ul></ul><ul><ul><li>Phase II Deliverables </li></ul></ul><ul><ul><li>Biotech Symposium </li></ul></ul>
    22. 22. Uppsala Biotech MC - Schedule Phase I Sponsor Organization Key Issue April 12-15 <ul><li>Dynamics of Regional Innovation Systems I (With Prof. Walshok) </li></ul><ul><ul><li>Tools for mapping the Uppsala Biotech Cluster </li></ul></ul>April 22 <ul><li>Kick-off Day in Uppsala </li></ul><ul><ul><li>Meet Uppsala BIO, researchers, Sponsor Organizations, and CEF participants </li></ul></ul>April 25 – June 3 <ul><li>Sponsor Organization Key Issue </li></ul><ul><ul><li>Key Issue development </li></ul></ul><ul><ul><li>Key Issue analysis and recommendations preparation </li></ul></ul>June 3 <ul><li>Uppsala Bio Day I at SSE </li></ul><ul><ul><li>Key Issue Report Presentation to Sponsor Organizations </li></ul></ul>Phase II Nordic Competitiveness in Biotechnology June 6 - 30 <ul><li>Dynamics of Regional Innovations Systems II (With Prof. Walshok) </li></ul><ul><ul><li>Comparing cluster dynamics – Uppsala and San Diego </li></ul></ul><ul><ul><li>Trip to San Diego </li></ul></ul><ul><li>Nordic Competitiveness in Biotechnology </li></ul><ul><ul><li>Investigation and assignment preparation </li></ul></ul>June 30 <ul><li>SSE MBA Symposium </li></ul><ul><ul><li>Symposium on Issues Shaping Nordic Competitiveness in Biotechnology </li></ul></ul>
    23. 23. The Dynamics of Regional Innovation Systems I Course Visiting Professor Mary Walshok, Univ. Of California, San Diego April 12-15 <ul><li>Objectives I </li></ul><ul><li>To differentiate between the dynamics of innovation in corporate environments and regional clusters </li></ul><ul><li>To understand the critical components of entrepreneurial regional innovation systems </li></ul><ul><li>Objectives II </li></ul><ul><li>To map the capabilities and shortcomings of the Uppsala Biotech Cluster </li></ul><ul><li>To have an understanding of the complementarities of the business and financial services clusters in the Stockholm region for Uppsala’s R&D capabilities </li></ul><ul><li>Results to be presented by students at the Uppsala Biotech Kick-off in Uppsala for the Uppsala Bio Cluster Initiative </li></ul>
    24. 24. The Uppsala Biotech Master Case Kick-off Master of Business Administration Program (MBA) Stockholm School of Economics (SSE) April 22, 2005 Robin Teigland, 070 781 4422 Martin Vidaeus, 070 232 2929
    25. 25. Master Case Kick-off Day in Uppsala Friday, April 22 <ul><li>Bus leaves Sveavägen 65 (Leaves at 8:30 sharp) </li></ul><ul><li>MBA Teams visit Uppsala BIO (1) </li></ul><ul><ul><li>Presentation by MBA Teams to Uppsala BIO based on the Dynamics of Regional Innovation Systems course </li></ul></ul><ul><li>MBA Teams visit Ångström, BMC, and Rudbeck Research Labs (2) </li></ul><ul><ul><li>Lunch </li></ul></ul><ul><ul><li>Presentation of research projects and labs </li></ul></ul><ul><li>MBA Teams visit their Sponsor Organization (3) </li></ul><ul><ul><li>Introduction and discussion of practicalities </li></ul></ul><ul><li>Mingle Dinner with Sponsor Organizations (4) </li></ul><ul><ul><li>At Värmlands Nation with Sponsor Organization Representatives </li></ul></ul><ul><ul><li>Bus leaves from Domkyrkan, 8:45 pm </li></ul></ul>12:30-15:00 15:30-17:30 18:00-20:30 9:30-12:00 8:15
    26. 26. <ul><li>Uppsala BIO – Science Park (9:30 -12:00) Dag Hammarskjölds väg 60, Uppsala (The bus will leave Sveavägen 65 at 8:30 sharp!) </li></ul><ul><li>Madeleine Neil </li></ul><ul><li>Uppsala BIO </li></ul><ul><li>018-57 23 53 </li></ul><ul><li>0768-29 77 77 </li></ul><ul><li>[email_address] </li></ul><ul><li>www.uppsalabio.com </li></ul><ul><ul><li>By train: </li></ul></ul><ul><ul><li>www.sj.se </li></ul></ul><ul><ul><li>Departs Arrives </li></ul></ul><ul><ul><li>Stockholm C Uppsala </li></ul></ul><ul><ul><li>7:40 -> 8:20 </li></ul></ul><ul><ul><li>8:10 -> 8:50 </li></ul></ul><ul><ul><li>8:40 -> 9:20 </li></ul></ul>
    27. 27. Map of Uppsala Bio and Research Labs Uppsala BIO
    28. 28. (2) Visit to Research Labs (12:30 – 15:00) <ul><li>BMC Lab, www.bmc.uu.se </li></ul><ul><ul><li>Resistentia and Svanova teams </li></ul></ul><ul><ul><li>Lab contact: Catharina Svensson, Catharina.Svensson@imbim.uu.se, tel: 018-471 4531 or 070-425 0385 </li></ul></ul><ul><ul><li>MBA contact: Barbara Kraus, barbara.kraus@mba.sse.edu </li></ul></ul><ul><li>Rudbeck Lab, www.rudbeck.uu.se </li></ul><ul><ul><li>BIO-X and Pharmacia teams </li></ul></ul><ul><ul><li>Lab contact: Mats Nilsson, mats@biocyclica.se, tel: 018-4714816 or 073-0537876 </li></ul></ul><ul><ul><li>MBA contact: Rickard Brorsson, rickard.brorsson@mba.sse.edu </li></ul></ul><ul><li>Ångström Lab, www.angstrom.uu.se </li></ul><ul><ul><li>QUIAtech and GE teams </li></ul></ul><ul><ul><li>Lab contact: Jan-Åke Schweitz, jan-ake.schweitz@angstrom.uu.se, tel: 018-471 30 89 </li></ul></ul><ul><ul><li>MBA contact: Gabriel Catrina, gabriel.catrina@mba.sse.edu </li></ul></ul>
    29. 29. (2) Uppsala Biotech MC Teams Rudbeck Lab Student names in red are team contacts Ångström Lab BMC Lab BIO-X QUIAtech Resistentia Rickard Brorsson Gabriel Catrina Barbara Kraus Jeanette Del Valle Tony Friede Stephan Kuratli Einar Gudmundsson Christine Edman Sebastian Lang Hans Johanssson Sören Holmblad Santosh Nair Alexandrs Pjatibratovs Emil Sunvisson Pontus Nylander Björn Svensson Dheva Raja Evaggelos Sempoglou Pharmacia GE Svanova Håkan Bengtsson Dogan Gegeoglu Erin Donaldson Eriks Ciguzis Patrik Bosander Magnus Fernström Jason Francis Karin Fisher Jerome Panoff Hester Fenwick Peter Vriesman Moritz Wendt Kristine Zelmene Krish Sailam Jun Okamoto Arwen Schreiber Roger Jacobsson Taavi Lepmets
    30. 30. (3a) Visit to Sponsor Organizations (15:30 – 17:30) <ul><li>BIO-X </li></ul><ul><ul><li>Company contact: Rhiannon Sanders, rhiannon.sanders@uppsalabio.com </li></ul></ul><ul><ul><li>www.uppsalabio.com, Tel: 070 601 93 20 </li></ul></ul><ul><ul><li>Located in Uppsala BIO’s offices </li></ul></ul><ul><ul><li>MBA contact: Rickard Brorsson, rickard.brorsson@mba.sse.edu </li></ul></ul><ul><li>GE Healthcare </li></ul><ul><ul><li>Company contact: Sven Henrichwark, sven.henrichwark@ge.com </li></ul></ul><ul><ul><li>www.amershambiosciences.com, Tel: 018 612 0000 </li></ul></ul><ul><ul><li>Located at Björkgatan 30, Uppsala </li></ul></ul><ul><ul><li>MBA contact Dogan Gegeoglu, dogan.gegeoglu@mba.sse.edu </li></ul></ul><ul><li>Pharmacia </li></ul><ul><ul><li>Company contact: Håkan Englund, hakan.englund@diagnostics.com </li></ul></ul><ul><ul><li>www.diagnostics.com, Tel: 018 16 50 60 </li></ul></ul><ul><ul><li>Located at Rapsgatan 7, Uppsala </li></ul></ul><ul><ul><li>MBA contact: Håkan Bengtsson, hakan.bengtsson@mba.sse.edu </li></ul></ul>
    31. 31. (3b) Visit to Sponsor Organizations (15:30 – 17:30) <ul><li>QUIAtech </li></ul><ul><ul><li>Company contact: Karen Frost, karen.frost@quiatech.com </li></ul></ul><ul><ul><li>www.quiatech.com, Tel: 018 57 23 80 </li></ul></ul><ul><ul><li>Located in Uppsala Science Park </li></ul></ul><ul><ul><li>MBA contact: Gabriel Catrina, gabriel.catrina@mba.sse.edu </li></ul></ul><ul><li>Resistentia </li></ul><ul><ul><li>Company contact: Bingze Xu, bingze.xu@resistentia.se </li></ul></ul><ul><ul><li>www.resistentia.se, Tel: 018 65 39 00 </li></ul></ul><ul><ul><li>Located at Kungsängsvägen 25 (near E4 entrance to Uppsala) </li></ul></ul><ul><ul><li>MBA contact: Barbara Kraus, barbara.kraus@mba.sse.edu </li></ul></ul><ul><li>Svanova </li></ul><ul><ul><li>Company contact: Christina Frimodig, christina.frimodig@svanova.com </li></ul></ul><ul><ul><li>www.svanova.com, Tel: 018 65 49 00 </li></ul></ul><ul><ul><li>Located in Uppsala Science Park </li></ul></ul><ul><ul><li>MBA contact: Erin Donaldson, erin.donaldson@mba.sse.edu </li></ul></ul>
    32. 32. (3c) Sponsor Organization Kick-off Visit: Suggested Activities <ul><li>Presentations </li></ul><ul><ul><li>MBA Team presents itself </li></ul></ul><ul><ul><li>Key individuals from Sponsor Organization present themselves, e.g., CEO, Business Development, Marketing, R&D, Finance, etc. </li></ul></ul><ul><ul><li>Presentation of Sponsor Organization and brief overview of Key Issue </li></ul></ul><ul><ul><ul><li>Provide MBA Team with potential resources, e.g., documents, information, etc. </li></ul></ul></ul><ul><li>Discussion of practicalities </li></ul><ul><ul><li>Scheduling of subsequent meeting times for Key Issue analysis and recommendations </li></ul></ul><ul><ul><li>Confidentiality , i.e., protection of intellectual property and sensitive company documents </li></ul></ul><ul><ul><li>Rules of engagement , i.e., Sponsor Organizations may want to clearly define whom MBA Team may contact and how they shall represent the Sponsor Organization in order to protect relationships with potential or active investors, customers, collaboration partners, etc. </li></ul></ul><ul><ul><li>Use of internal resources , e.g., internal marketing or business strategy documents, top-level R&D reports, and their return to the Sponsor Organization </li></ul></ul><ul><ul><li>Acquisition of external resources , e.g., basic cell biology primer references, third party market research studies, company reports, etc. </li></ul></ul>
    33. 33. (4) Mingle Dinner at Värmlands Nation, (18-20:30, Bus leaves at 20:45) <ul><li>Värmlands nation </li></ul><ul><ul><li>Contact: Erik Holmquist,uthyrning@varmlandsnation.se </li></ul></ul><ul><ul><li>www.varmlandsnation.se, Tel: 018 13 44 45 </li></ul></ul><ul><ul><li>Located at Nedre Slottsgatan 2  </li></ul></ul><ul><li>Departure for Stockholm </li></ul><ul><ul><li>By bus </li></ul></ul><ul><ul><ul><li>8:45 pm </li></ul></ul></ul><ul><ul><ul><li>At Domkyrkan </li></ul></ul></ul><ul><ul><li>By train </li></ul></ul><ul><ul><ul><li>www.sj.se </li></ul></ul></ul><ul><ul><ul><li>Departs Arrives </li></ul></ul></ul><ul><ul><ul><li>Uppsala Stockholm </li></ul></ul></ul><ul><ul><ul><li>20:10 -> 20:50 </li></ul></ul></ul><ul><ul><ul><li>21:10 -> 21:50 </li></ul></ul></ul><ul><ul><ul><li>21:27 -> 22:05   </li></ul></ul></ul>
    34. 34. (4) Mingle with CEF Students <ul><li>We will be joined at the dinner by students from the Masters program at the Centre for Entrepreneurship and Enterprise Development at Uppsala University. </li></ul><ul><ul><li>Small program with 25 students per year </li></ul></ul><ul><ul><li>Students have a background in science and engineering and are interested in business development and entrepreneurship </li></ul></ul><ul><ul><li>The one-year program combines courses (business development, marketing, IPR and contract law, negotiation, organization theory and management, leadership, teambuilding, and emotional competence) with a live innovation project with an Uppsala firm </li></ul></ul><ul><ul><li>For more information, see http://www.cef.uu.se/ (in Swedish) </li></ul></ul>
    35. 35. The Uppsala Biotech Master Case Phase I Deliverables Master of Business Administration Program (MBA) Stockholm School of Economics (SSE) June 2, 2005
    36. 36. Uppsala Biotech MC Sponsor Organizations & Key Issues* BIO-X *Projects have been generalized due to confidentiality aspects. How to ensure research project success? How to commercialize a technology? How to develop a technology more efficiently? How to increase market share in existing products in existing geographical markets? How to enter an existing geographical market with a new product? How to increase profits on existing products in existing markets?
    37. 37. The Next Few Weeks in Phase I <ul><li>Friday, June 3rd </li></ul><ul><ul><li>Biotech Day I </li></ul></ul><ul><ul><li>5 minute Presentation of project for all students and company reps </li></ul></ul><ul><ul><li>Final Presentation of Key Issue for Sponsor Organization </li></ul></ul><ul><li>Sunday, June 12th </li></ul><ul><ul><li>Final Report due 13:00 </li></ul></ul><ul><li>Monday, June 13th </li></ul><ul><ul><li>Assignment of groups for Phase II of Uppsala Biotech Master Case </li></ul></ul><ul><ul><li>More information on June 13th </li></ul></ul>
    38. 38. Uppsala Biotech MC Phase I Deliverables <ul><li>Final Presentation </li></ul><ul><ul><li>PPT presentation </li></ul></ul><ul><ul><li>Designed for Biotech Day I </li></ul></ul><ul><ul><li>To be submitted on May 27th, 23:55 </li></ul></ul><ul><ul><li>To be presented on June 3rd </li></ul></ul><ul><li>Final Report </li></ul><ul><ul><li>Stand-alone document – not dependent on presentation </li></ul></ul><ul><ul><li>Format of Word, PPP, or “hybrid” – you choose </li></ul></ul><ul><ul><li>Executive Summary - maximum 2 pages in word </li></ul></ul><ul><ul><li>Can build on June 3rd Final Presentation </li></ul></ul><ul><ul><li>To be submitted on June 12th, 13:00 </li></ul></ul>
    39. 39. Criteria for Uppsala Biotech MC Phase I Deliverables <ul><li>Key issue analysis </li></ul><ul><ul><li>Clear purpose of investigation </li></ul></ul><ul><ul><li>Purpose adequately analyzed and fulfilled </li></ul></ul><ul><ul><li>Appropriate theory and tools used and explained </li></ul></ul><ul><ul><li>Well substantiated results </li></ul></ul><ul><li>Presentation </li></ul><ul><ul><li>Well structured and clear, logical storyline </li></ul></ul><ul><ul><li>Concise, convincing key messages supported through data or detail </li></ul></ul><ul><ul><li>Well designed </li></ul></ul><ul><ul><li>Clearly visualized and within time constraints (Presentation only) </li></ul></ul><ul><li>Value delivered to company </li></ul><ul><ul><li>Recommendations that are feasible and actionable </li></ul></ul><ul><ul><li>Effective in stimulating action </li></ul></ul><ul><ul><li>Favorable response from Company </li></ul></ul><ul><ul><li>Interested Q&A from Company (Presentation only) </li></ul></ul>It’s for the company and not for me!
    40. 40. Uppsala Biotech MC Deliverables – Final Presentation Biotech Day I, June 3rd <ul><li>Biotech Day 5 Minute Presentation (A) </li></ul><ul><ul><li>A 5 minute presentation to be made to the entire group of students and company representatives that gives a brief overview of your project, e.g., key issue, method & analysis (i.e., how you went about addressing the key issue), challenges, and lessons learned. But do NOT include conclusions or recommendations due to confidentiality aspects. The idea is to tell others about the type of project that you did and how you went about it so that the audience can learn from your experience if they are faced with doing such a project one day. </li></ul></ul><ul><li>Final Presentation (B) </li></ul><ul><ul><li>This is the final presentation you will make to your company, but do not see it as the final product. (The final product is the Final Report to be submitted on June 12th.) Thus, for the Final Presentation to be submitted on May 27th, push as far as you can for closure on your project. You will then have ~3 hours to make this presentation to your company on Biotech Day on June 3rd (1.5 hours in morning, and 1.5 hours after lunch). Use these three hours to discuss things such as issues that might still need some work, your recommendations and how they might be implemented, etc. </li></ul></ul><ul><ul><li>I will give you feedback on your presentations hopefully by Monday, May 30th, so that you will have some time to make changes before the presentation on Friday, June 3rd. </li></ul></ul><ul><ul><li>Don’t forget to take a look at the Storyboard Approach document that I handed out recently for some presentation tips. In addition to the content of the presentation, I will be looking for things such as a clear, logical storyline and key messages on each slide. See Criteria for Phase I Deliverables slide in this document for more information. </li></ul></ul>
    41. 41. Uppsala Biotech MC Deliverables – Final Report Due June 12th, 13:00 <ul><li>Remember who the reader is! </li></ul><ul><ul><li>This report is to be written for your company. One idea is to ask your company how they intend to use this report, e.g., developing new internal routines, approaching VCs for financing, etc., and then tailor it appropriately . </li></ul></ul><ul><ul><li>Please write the report so that if anyone from your MC company picks it up, he or she can understand what it is about. </li></ul></ul><ul><ul><li>Use the SSE MBA template and give a background of SSE MBA, MBA Live, the Master Case, and who you are. </li></ul></ul><ul><ul><li>I will give you feedback on this report before we present it to the company. In some cases, some of this feedback may need to be incorporated before we present it. </li></ul></ul><ul><li>Keep the reader’s attention! </li></ul><ul><ul><li>This report (in Word) may build on your Final Presentation to the company, thus you may use the powerpoint slides in the body of the document. If you do this, then discuss these slides in the body of your report, label them as figure x, and refer to the figures in the body of the report. </li></ul></ul><ul><ul><li>Keep the report eye-catching by using headings, bullet points, and figures. </li></ul></ul><ul><ul><li>Summarize each section with a key message either in the margin next to the section or highlighted at the end of the section. These key messages should tell the story throughout the report so that it makes it easy for the reader to follow. </li></ul></ul><ul><ul><li>Look at the Connecting Firms Master’s thesis that I handed out in your rooms as an example. </li></ul></ul>
    42. 42. The Uppsala Biotech Master Case Biotech Day Master of Business Administration Program (MBA) Stockholm School of Economics (SSE) June 3, 2005
    43. 43. Uppsala Biotech Day I – June 3rd, 2005 At SSE MBA <ul><li>Morning Coffee Mingle   </li></ul><ul><li>Overview of Uppsala Biotech Master Case </li></ul><ul><ul><li>MBA Teams, Sponsor Organization Reps, and SSE MBA Faculty together </li></ul></ul><ul><ul><li>MBA Teams present Summaries of their Uppsala Biotech Master Case Project (5 minutes each) (A) </li></ul></ul><ul><li>Presentation of Key Issue Recommendations </li></ul><ul><ul><li>Break out into group rooms </li></ul></ul><ul><ul><li>Each MBA Team presents its report and recommendations to its Sponsor Organization individually (B) </li></ul></ul><ul><li>Lunch at SSE MBA Suite </li></ul><ul><li>Presentation of Key Issue Recommendations </li></ul><ul><ul><li>MBA Team presentations and discussions continue in group rooms (B Cont’d.) </li></ul></ul><ul><ul><li>Sponsor Organization Reps prepare their feedback and comments on the Key Issue Recommendations by the MBA Team </li></ul></ul><ul><li>Feedback by Sponsor Organization Representatives </li></ul><ul><ul><li>MBA Teams, Sponsor Organization Reps, and SSE MBA Faculty together </li></ul></ul><ul><ul><li>Sponsor Organization Reps give their feedback on their MBA Team’s work </li></ul></ul><ul><ul><li>Plenary Q&A session </li></ul></ul>9:00- 9:30 9:30-10:30 10:30-12:00 12:00-13:00 13:00-14:30 14:30-15:30
    44. 44. Feedback by Sponsor Organization to MBA Team <ul><li>Please prepare a brief presentation on the following: </li></ul><ul><ul><li>Your group’s Key Issue </li></ul></ul><ul><ul><li>Your group’s presentation </li></ul></ul><ul><ul><li>Value delivered to you by your group </li></ul></ul><ul><ul><li>Any other thoughts, feedback, or constructive criticism? </li></ul></ul><ul><li>See hand-out for more information </li></ul>
    45. 45. Overview of Uppsala Biotech Master Case <ul><li>Introduction to SSE MBA Students </li></ul><ul><li>Introduction to Uppsala Biotech Master Case </li></ul><ul><li>Overview of Uppsala Biotech MC Phase I </li></ul><ul><ul><li>Dynamics of Regional Innovation Systems with Prof. Walshok </li></ul></ul><ul><ul><li>Uppsala Biotech Master Case Kick-off in Uppsala </li></ul></ul><ul><ul><li>Phase I Deliverables </li></ul></ul><ul><ul><li>Biotech Day I </li></ul></ul><ul><li>Overview of Uppsala Biotech MC Phase II </li></ul><ul><ul><li>Dynamics of Regional Innovation Systems with Prof. Walshok, trip to San Diego </li></ul></ul><ul><ul><li>Phase II Deliverables </li></ul></ul><ul><ul><li>Biotech Symposium </li></ul></ul>
    46. 46. Uppsala Biotech MC - Schedule Phase I Sponsor Organization Key Issue April 12-15 <ul><li>Dynamics of Regional Innovation Systems I (With Prof. Walshok) </li></ul><ul><ul><li>Tools for mapping the Uppsala Biotech Cluster </li></ul></ul>April 22 <ul><li>Kick-off Day in Uppsala </li></ul><ul><ul><li>Meet Uppsala BIO, researchers, Sponsor Organizations, and CEF participants </li></ul></ul>April 25 – June 3 <ul><li>Sponsor Organization Key Issue </li></ul><ul><ul><li>Key Issue development </li></ul></ul><ul><ul><li>Key Issue analysis and recommendations preparation </li></ul></ul>June 3 <ul><li>Uppsala Bio Day I at SSE </li></ul><ul><ul><li>Key Issue Report Presentation to Sponsor Organizations </li></ul></ul>Phase II Nordic Competitiveness in Biotechnology June 6 - 30 <ul><li>Dynamics of Regional Innovations Systems II (With Prof. Walshok) </li></ul><ul><ul><li>Comparing cluster dynamics – Uppsala and San Diego </li></ul></ul><ul><ul><li>Trip to San Diego </li></ul></ul><ul><li>Nordic Competitiveness in Biotechnology </li></ul><ul><ul><li>Investigation and assignment preparation </li></ul></ul>June 30 <ul><li>SSE MBA Symposium </li></ul><ul><ul><li>Symposium on Issues Shaping Nordic Competitiveness in Biotechnology </li></ul></ul>
    47. 47. Dynamics of Regional Innovation Systems II Course Trip to San Diego, June 18-25, with Prof. M. Walshok Itinerary CO    69  18 June  Arlanda-New York, Newark   0925/1210 CO 1426           Newark-San Diego               1735/2023   CO 1827  25 June  San Diego-Newark                0800/1628 CO   68    25 June  Newark-Arlanda                   1800/0755 (26/6) Sun Mon Tue Wed Thu Fri Sat 19 20 21 22 23 24 25 10:00: Orientation to campus and program Overview of campus, city, program resources Walk to beach (optional) Free evening Theme: The Research Base 8:30-11:45 Lectures 12:00 Lunch with life-sci entrepreneur 1:45-2:45 Orientation to projects 3:00-4:30 Tour One: The Research Mesa (possibly on foot) Theme: Knowledge Transfer Mechanisms 8:30-10:00 Lecture 10:15-11:45 CONNECT as a Catalyst for Innovation 12:00 Lunch with CONNECT posterchild 1:45-3:15 (+) Tour Two: Sorrento Valley, North City West, Visit to Qualcomm Theme: Sources of Capital 8:30-10:00 Overview of Funding Sources: VC’s, Angels, Corporate Partners 10:15-11:45 TCA presentation 12:00 Lunch with entrepreneur who has been thro gamut of financing 1:45-3:15 (+) Work on projects Evening (gametime 7:05): Baseball game SD Padres vs. LA Dodgers Theme: Globalization; and Service Sector Infrastructure 8:30-10:00 Globalization of Innovation 10:15-11:45 Lecture on service sector 12:00 Lunch with local entrepreneur or service sector representative 1:45-2:45: Clusters (Mary and Orjan) Remainder of afternoon: work on projects Presentations Morning: completion of projects 12:00: Lunch 1:00-4:30 Student presentations 6:30: Farewell dinner and Midsummer Celebration (Mary’s house) Depart San Diego (8:00am flight)
    48. 48. The Final Stretch Uppsala Biotech MC Phase II Deliverables Master of Business Administration Program (MBA) Stockholm School of Economics (SSE) June 24, 2005
    49. 49. The Final Stretch <ul><li>Friday, June 24 th (in San Diego) </li></ul><ul><ul><li>Presentation of Symposium Poster Presentation (Draft) </li></ul></ul><ul><ul><li>20 minutes total for discussion for each team in afternoon </li></ul></ul><ul><li>Monday, June 27th </li></ul><ul><ul><li>Class Meeting, 13:15-15:00, practical preparation for Symposium </li></ul></ul><ul><ul><li>Professor Walshok’s Individual Reflection due 17:00 </li></ul></ul><ul><li>Tuesday, June 28th </li></ul><ul><ul><li>Final Symposium Poster Presentation & Hand-out due, midnight </li></ul></ul><ul><li>Wednesday, June 29th </li></ul><ul><ul><li>Class Meeting, 9:00-12:00, Presentation of Poster Presentation to class </li></ul></ul><ul><ul><li>Class Meeting, 13:15-17:00, Preparation for Symposium, booths, etc. </li></ul></ul><ul><li>Thursday, June 30th </li></ul><ul><ul><li>Symposium, 7:00–14:00 </li></ul></ul><ul><ul><li>Symposium clean-up, 14:00-17:00 </li></ul></ul>
    50. 50. Uppsala Biotech MC Phase II Deliverables <ul><li>Symposium Poster Presentation </li></ul><ul><ul><li>Presentation to fit within one large poster (TBA) </li></ul></ul><ul><ul><li>Designed for discussion with public at Biotech Symposium </li></ul></ul><ul><ul><li>Final due June 28th, midnight </li></ul></ul><ul><li>Symposium Poster Hand-out </li></ul><ul><ul><li>Stand-alone document – Builds on Presentation </li></ul></ul><ul><ul><li>Format of Word, PPT, or “hybrid” – you choose </li></ul></ul><ul><ul><li>Minimum 9 pages </li></ul></ul><ul><ul><li>To be handed out to public at Symposium </li></ul></ul><ul><ul><li>Final due on June 28th, midnight </li></ul></ul>
    51. 51. Poster Presentation <ul><li>What is a poster? </li></ul><ul><ul><li>A visually accessible summary of a project </li></ul></ul><ul><ul><li>A means for many people to share a lot of information in a short period of time </li></ul></ul><ul><li>Key Components </li></ul><ul><ul><li>What are the primary points/findings? </li></ul></ul><ul><ul><li>What sources did you use? </li></ul></ul><ul><ul><li>How can the reader go forward? E.g., websites, organizations, etc. </li></ul></ul>
    52. 52. Biotech Symposium MBA Student Poster Themes <ul><li>MBA Team Uppsala BIO-X </li></ul><ul><ul><li>How to attract “smart money”? Early commercialization from finance perspective, VC methods, criteria </li></ul></ul><ul><li>MBA Team QUIAtech </li></ul><ul><ul><li>How to change the entrepreneurial mindset from molecules to money? </li></ul></ul><ul><li>MBA Team Resistentia </li></ul><ul><ul><li>How to do research more efficiently? A focus on China </li></ul></ul><ul><li>MBA Team Svanova </li></ul><ul><ul><li>Contrasting European and US VC funding: W hat can Sweden/Nordic region learn and improve? </li></ul></ul><ul><li>MBA Team Pharmacia </li></ul><ul><ul><li>What are the major challenges of introducing an OTC product in the Californian/US market? </li></ul></ul><ul><li>MBA Team GE Healthcare </li></ul><ul><ul><li>How to merge large corporate culture and professionalism into a smaller biotech company? Both perspectives </li></ul></ul>
    53. 53. Criteria for Uppsala Biotech MC Phase II Deliverables <ul><li>Key theme analysis </li></ul><ul><ul><li>Clear focus </li></ul></ul><ul><ul><li>Focus adequately analyzed and fulfilled </li></ul></ul><ul><ul><li>Appropriate theory and tools used and explained </li></ul></ul><ul><li>Symposium Poster Presentation & Hand-out </li></ul><ul><ul><li>Well structured and clear, logical storyline </li></ul></ul><ul><ul><li>Concise, convincing key messages supported through data or detail </li></ul></ul><ul><ul><li>Well designed and clearly visualized </li></ul></ul><ul><li>Value delivered to general public </li></ul><ul><ul><li>Effective in stimulating discussion </li></ul></ul><ul><ul><li>Interested Q&A from Symposium public </li></ul></ul><ul><ul><li>If appropriate, recommendations that are feasible and actionable </li></ul></ul>It’s for the public and not for me!
    54. 54. Uppsala Biotech MC Phase II Deliverables <ul><li>Remember who the reader is! </li></ul><ul><ul><li>These deliverables are for the general public. </li></ul></ul><ul><ul><li>Please write the hand-out so that if anyone picks it up, he or she can understand what it is about. </li></ul></ul><ul><ul><li>Use the SSE MBA template and give a background of SSE MBA, MBA Live, the Master Case, and who you are. </li></ul></ul><ul><li>Keep the reader’s attention! </li></ul><ul><ul><li>Keep the deliverables eye-catching by using headings, bullet points, and figures. </li></ul></ul>
    55. 55. Symposium on Issues Shaping Nordic Competitiveness in Biotechnology Stockholm School of Economics (SSE) Master of Business Administration Program (MBA) June 30, 2005
    56. 56. Symposium Practical Activities by Students <ul><li>Symposium Set-up (7:30 to 9:00) </li></ul><ul><ul><li>MBA Team BIO-X </li></ul></ul><ul><ul><li>MBA Team GE Healthcare </li></ul></ul><ul><li>Symposium Registration (8:00 – 9:00) </li></ul><ul><ul><li>MBA Team Pharmacia </li></ul></ul><ul><li>Symposium Clean-up (14:00 – 16:00) </li></ul><ul><ul><li>MBA Team Resistentia </li></ul></ul><ul><ul><li>MBA Team Svanova </li></ul></ul><ul><ul><li>MBA Team QUIAtech </li></ul></ul>
    57. 57. SSE MBA Student Participation in Symposium <ul><li>Presentation of SSE MBA in Symposium Introduction </li></ul><ul><ul><li>“ Why is Biotech Interesting for Business Schools?” by Emil S. </li></ul></ul><ul><li>Participation in Panel Discussions </li></ul><ul><ul><li>No presentation, but participate in discussion </li></ul></ul><ul><ul><li>1 hr 15 min for each panel </li></ul></ul><ul><ul><li>One student on each panel </li></ul></ul><ul><ul><ul><li>Company Perspective by Krish S. </li></ul></ul></ul><ul><ul><ul><li>Policy Perspective by Barbara K. </li></ul></ul></ul><ul><li>Presentation of MBA Poster Themes </li></ul><ul><ul><li>Introduction of Poster Session by Tony F. </li></ul></ul><ul><li>Poster Discussion </li></ul><ul><ul><li>During coffee break and one hour session after panel discussions </li></ul></ul><ul><ul><li>One presentation per group, all group members participate </li></ul></ul>
    58. 58. Issues Shaping Nordic Competitiveness in Biotechnology SSE MBA Inaugural Symposium June 30th, Stockholm School of Economics, Sveavägen 65, Stockholm Stockholm School of Economics Dr. Ketels has led competitiveness projects across the globe, including work on the Massachusetts Biotech Cluster, and is currently conducting an analysis of the competitiveness of the greater Stockholm region with the OECD. Keynote Speaker I Mads Øvlisen Chairman of the Board Novo Nordisk A/S Mads Øvlisen is Chairman of the Board as well as former President and CEO of Novo Nordisk. He is also Chairman of LEGO A/S, the Danish Royal Theatre, and the Wanås Foundation and Adjunct Professor at the Copenhagen Business School. To register (free), contact Helena Kvist-Åslund, helena.aslund@hhs.se, +46 (8) 736-9598 In addition to SSE MBA students, other Session Panelists include: Johan Christenson, Partner, HealthCap Nigel Darby, VP, GE Healthcare Laura Howard, MD, Morgan Stanley, UK Ulf Landegren, Professor, Uppsala Univ. Björn Nilsson, SVP, Biacore Mats Pettersson, CEO, Biovitrum Peter Sellei, VP, Investor AB Ylva Williams, Director, Life Science, ISA Keynote Speaker II Dr. Christian Ketels Head Prof. Porter’s Research Team Institute of Strategy and Competitiveness Harvard Business School
    59. 59. SSE MBA Biotech Symposium Time Event Thursday, June 30, 2005 Registration Symposium Welcome Robin Teigland, SSE MBA Session II. The Policy Perspective Nordic Biotech in 2020 – Copying the US or Finding its Own Model? Speaker: Christian Ketels, Harvard Business School Panel Moderator: Robin Teigland, SSE MBA Session I. The Company Perspective How Do We Overcome the Challenges Facing Nordic Biotech Firms? Speaker: Mads Øvlisen, Chairman, Novo Nordisk Panel Moderator: Hans Nyctelius, President, SwedenBIO SSE MBA Poster Session and Coffee Break Symposium Wrap-Up Björn Nilsson, SVP, Biacore; Chairman, SwedenBIO Light Lunch, Mingle, and SSE MBA Poster Session (cont’d) 9:00 - 9:15 8:30 - 9:00 9:15 - 10:30 10:30 - 11:00 11:00 - 12:15 12:15 - 12:30 12:30 - 14:00
    60. 60. Issues Shaping Nordic Competitiveness in Biotechnology June 30, 2005 9:00 to 14:00 Stockholm School of Economics Sveavägen 65 <ul><li>Session I Panelists </li></ul><ul><li>Nigel Darby has 17 years of academic research experience, mainly in molecular biology, after which he worked at Astra Zeneca. Currently, he is VP at GE Healthcare, responsible for R&D & Product Management in the protein separations business. </li></ul><ul><li>Laura Howard is Managing Director in Morgan Stanley's European Healthcare Group, responsible for the European Biotech Franchise. Prior to her 10 years at Morgan Stanley, she worked with the MAC Group and Goldman Sachs. </li></ul><ul><li>Ulf Landegren is Professor at Uppsala University where he heads the Research Group on Molecular Medicine in the Department of Genetics and Pathology. </li></ul><ul><li>Mats Pettersson is CEO of Biovitrum since its founding in 2001. Prior to Biovitrum, Mats was SVP and Member of the Management Committee of Pharmacia Corporation. Mats has a B.Sc. in Economics and Business Administration. </li></ul><ul><li>Krish Sailam is an SSE MBA student. He has worked with business strategy for both MNCs and start-ups in Asia Pacific and North America with commercialization of technology from the university level. </li></ul><ul><li>Session II Panelists </li></ul><ul><li>Johan Christenson has a PhD from Karolinska Institute and has held management positions at Astra and Astra Zeneca. He is currently a Partner at HealthCAP. </li></ul><ul><li>Barbara Kraus is an SSE MBA student and has previously worked with Accenture. She holds a law degree from the university of Passau and has studied and worked extensively in the Czech Republic and Russia.  </li></ul><ul><li>Björn Nilsson has over 20 years experience in the pharmaceutical and biotech industry in both commercial and scientific roles. He chairs the Swedish biotechnology organization (SwedenBIO) and serves as SVP at Biacore International AB. </li></ul><ul><li>Peter Sellei is responsible for the Healthcare Sector in the Core Holdings Department at Investor AB. He has considerable experience as an academic researcher at Karolinska and as an analyst at firms such as Carnegie and Orkla. </li></ul><ul><li>Ylva Williams is Director of the Bio Science Project at the Invest in Sweden Agency. She has an MSc from the Royal Institute of Technology in molecular biology and has considerable managerial experience at VWR International and Pharmacia Biotech. </li></ul><ul><li>Symposium Introduction Speech </li></ul><ul><li>Emil Sunvisson is an SSE MBA student, honored with the MBA Leadership Award. He holds am MSc from the Royal Institute of Technology and is founder and chairman of Billskill AB, a company enabling telecom operators. </li></ul><ul><li>SSE MBA Poster Session Introduction </li></ul><ul><li>Tony Friede is an SSE MBA student, and his previous responsibilities include representing the Nordic region within Cap Gemini's global steering committee for CRM.  He holds a BSc in Electrical Engineering from the University of Kansas. </li></ul>
    61. 61. SESSION I. THE COMPANY PERSPECTIVE Keynote Speaker: Mads Øvlisen Chairman of the Board, Novo Nordisk A/S Mads Øvlisen is former president and CEO of Novo Nordisk and is chairman of several boards: the Danish Royal Theatre, LEGO A/S, and the Wanås Foundation, Sweden. He is also an adjunct professor at the Copenhagen Business School. Moderator: Hans Nyctelius President, SwedenBIO Hans Nyctelius has seventeen years of working experience from the Life Science industry with the last six years in management consultancy at Arthur D. Little and the Boston Consulting Group. He also holds an MBA with distinction from the Warwick Business School (UK). SESSION II. THE POLICY PERSPECTIVE Keynote Speaker: Dr. Christian Ketels Head of Professor Michael Porter’s Research Team Institute of Strategy and Competitiveness Harvard Business School Dr. Ketels has led competitiveness projects across the globe, including work on the Massachusetts Biotech Cluster, and is a member of numerous economic advisory groups in Europe and the Americas. He holds a PhD (Econ) from the London School of Economics. Moderator: Robin Teigland Core Faculty, SSE MBA Robin Teigland’s teaching interests parallel her research interests as she teaches “The Uppsala Biotech Cluster”, a live case that SSE MBA offers its students. She holds a BA (Econ) with distinction from Stanford and an MBA from Wharton, and prior to obtaining her PhD at SSE, she worked as a consultant with McKinsey & Co. For information on the other participants, please see the back. 8:30 – 9:00 9:00 – 9:15 9:15 – 9:30 10:30 – 11:00 11:00 – 12:15 12:15 – 12:30 12:30 – 14:00 Registration Symposium Welcome Robin Teigland, SSE MBA Emil Sunvisson, SSE MBA Session I. The Company Perspective: How Do We Overcome the Challenges Facing Nordic Biotech Firms? Speaker: Mads Øvlisen, Novo Nordisk Moderator : Hans Nyctelius, SwedenBIO Panelists: Nigel Darby, GE Healthcare Laura Howard, Morgan Stanley Ulf Landegren, Uppsala University Mats Pettersson, Biovitrum Krish Sailam, SSE MBA SSE MBA Poster Session & Coffee Break Tony Friede, SSE MBA Session II. The Policy Perspective: Nordic Biotech in 2020 – Copying the US or Finding its Own Model? Speaker : Christian Ketels, HBS Moderator : Robin Teigland, SSE MBA Panelists: Johan Christenson, HealthCap Barbara Kraus, SSE MBA Björn Nilsson, Biacore International Peter Sellei, Investor AB Ylva Williams, Invest in Sweden Agency Symposium Wrap-up Björn Nilsson, Biacore International Light Lunch & SSE MBA Poster Session (cont.) Today’s Program
    62. 62. SSE MBA Poster Themes Improving Commercialization of Research How to Choose VC Funding Interested in China for Biotech R&D? M&A Management: A Must for Biotech California 101 – Working within a Californian Biotech Culture Stockholm/Uppsala - A Unified Bio Zone Collaboration for Regional and Global Competitiveness
    63. 63. Symposium Write-up in Sweden’s Largest Newspaper
    64. 64. More Symposium Information <ul><li>For more information on the symposium, please visit SwedenBio’s homepage at www.swedenbio.com </li></ul><ul><ul><li>http://www.swedenbio.com/templates/Page.aspx?id=1367 </li></ul></ul><ul><ul><li>The posters and speaker presentations can also be found here </li></ul></ul>
    65. 65. Uppsala Biotech MC Contact Information <ul><li>Robin Teigland </li></ul><ul><li>Uppsala Biotech MC Coach </li></ul><ul><li>Stockholm School of Economics </li></ul><ul><li>08-736 9000 </li></ul><ul><li>[email_address] </li></ul><ul><li>www.sse.edu/MBA </li></ul><ul><li>www.knowledgenetworking.org </li></ul>Martin Vidaeus Uppsala Biotech MC Advisor 070-232 2929 [email_address] Madeleine Neil Uppsala BIO Communications 018-57 23 53 0768-29 77 77 [email_address] www.uppsalabio.com Feel free to contact Robin at any time!
    1. A particular slide catching your eye?

      Clipping is a handy way to collect important slides you want to go back to later.

    ×